Michele Fox, M.D. Professor of Pathology
Director, Cell Therapy and Transfusion Medicine
M.D., Karolinska Institute, Sweden Residency (medicine), Georgetown University Hospital, Washington, D.C. Fellowship (medical oncology, hematology), Georgetown University Hospital Senior Staff Fellow, National Institutes of Health, Bethesda, Maryland Clinical Assistant Professor, Bone Marrow Transplantation, Georgetown University Hospital
Associate Professor, Blood and Marrow Transplant Program, Greenebaum Cancer Center,
University of Maryland Special interests: stem
cell biology, transfusion medicine
Selected Publications:
T cell depleted bone marrow
transplantation and delayed T cell add-back to control acute GVHD and conserve a
graft-vs-leukemia effect. Bone Marrow Transplantation 21:543-551, 1998.
Plasma
concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients
undergoing peripheral blood stem cell transplants. Journal of Clinical Oncology 86(3): 1218-1227, 1998
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.